Abbott announced positive early results from the VERITAS study that show clinically meaningful closure rates of the investigational Amulet 360 Left Atrial Appendage (LAA) Occluder, a next-generation ...

As Valentine’s Week reaches its penultimate day, the air gets a little warmer and hearts beat a little closer. February 12 marks Hug Day, perhaps the most comforting day of the entire "week of love." ...

Valentine's Week's Hug Day on February 12th emphasizes genuine connection over digital interactions. Science confirms hugs release oxytocin, reducing stress and fostering safety. The article offers ...

Abbott has reported positive early data from the VERITAS study, evaluating its investigational Amulet 360 left atrial appendage (LAA) occluder, designed to reduce stroke risk in patients with ...

The month of love and romance brings with it excitement and lots of vows. It not only means looking forward to spending quality time with loved ones, but a favourable time to plan the perfect date, ...

A first look at the implant success and sealing efficacy of a dual-seal left atrial appendage occlusion (LAAO) device that’s in development reveals successful implantation in 99.8% of people with ...

It is first thing in the morning and nurses are waiting to take Michael Robinson to theatre. He has been living with atrial fibrillation (AF), a common heart rhythm problem, affecting 1.4m people in ...

BOSTON--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, ...